US2004048352A1PendingUtilityA1

Immortal avian cells

Priority: May 23, 1996Filed: Sep 9, 2003Published: Mar 11, 2004
Est. expiryMay 23, 2016(expired)· nominal 20-yr term from priority
C12N 5/0602C12N 2501/48C12N 2510/04C12N 2510/02
55
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention features apoptosis-resistant, non-transformant immortalised avian cells, in particular, avian tissues, i.e., other than blood or haematopoietic cells, particularly fibroblasts and epithelial cells, for instance embryos.

Claims

exact text as granted — not AI-modified
1 . A method for producing viruses in an avian cell line, said method comprising: 
 (i) providing avian cells which are immortalized, but untransformed, and which comprise an anti-apoptotic bcl-2 gene into their genome;    (ii) culturing said avian cells;    (iii) infecting said cultivated avian cells with a virus and producing said virus.    
     
     
         2 . The method of  claim 1 , wherein the cultivated avian cells are chronically infected by the virus.  
     
     
         3 . The method of  claim 1 , wherein the virus is an avian virus.  
     
     
         4 . The method of  claim 1 , wherein the virus is a duck virus.  
     
     
         5 . The method of  claim 1 , wherein the virus is chosen among the group consisting of duck adenovirus, duck parvovirus and duck reovirus.  
     
     
         6 . The method of  claim 1 , wherein the virus is chosen among the group consisting of poxvirus, canarypox, fowlpox, Marek's Disease Virus serotype 1, Marek's Disease Virus serotype 2, HVT and Gumboro disease virus.  
     
     
         7 . The method of  claim 1 , wherein the cells comprise, integrated into their genome, the SV40 T+t gene.  
     
     
         8 . The method of  claim 7 , wherein the SV40 T+t gene is under the control of the MTI promoter.  
     
     
         9 . The method of  claim 4 , wherein the cell line is cell line TDF-2A bcl-2, which is deposited in the CNCM under reference number I-1709.  
     
     
         10 . The method of  claim 3 , wherein the cell line is cell line TCF-4.10 bcl-2, which is deposited in the CNCM under reference number I-1711.

Join the waitlist — get patent alerts

Track US2004048352A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.